Merck’s Pancreatic Cancer Treatment Gets FDA Nod
Merck shares were up handily on Tuesday after the company announced a key update from the FDA on its Lynparza for the treatment of pancreatic cancer......»»
AstraZeneca"s (AZN) Lynparza Gets Another Orphan Drug Status
AstraZeneca (AZN) and partner Merck's Lynparza receive Orphan Drug designation (ODD) by the FDA for the treatment of pancreatic cancer. AstraZeneca plc AZN and .....»»
Surface Oncology treatment of pancreatic cancer granted FDA orphan status
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Marriott President and CEO Arne Sorenson to reduce schedule for pancreatic cancer treatment
Marriott International Inc. said Tuesday that President and Chief Executive Arne Sorenson will temporarily scale back his schedule to allow him to have more demanding treatment for pa.....»»
Merck: EC approves KEYTRUDA for treatment of MSI-H, dMMR colorectal cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AIM ImmunoTech granted FDA orphan designation for pancreatic cancer treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck-AstraZeneca"s Lynparza Snags FDA Nod For Pancreatic Cancer
In what co.....»»
AstraZeneca, Merck say Lynparza approved in U.S. in gBRCAm pancreatic cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Civil rights icon Rep. John Lewis will undergo treatment for stage 4 pancreatic cancer
Alex Wong/Getty Images Democratic Rep. John Lewis of Georgia has been diagnosed with stage 4 pancreatic cancer and is undergoing treatment. In a stat.....»»
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Merck KGaA and Pfizer said Friday that a late-stage clinical trial testing Bavencio as a first-line maintenance treatment for patients with certain forms of gastric cancer failed to meet the study's primary endpoints for survival. The cur.....»»
Ipsen treatment of pancreatic cancer granted orphan status
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eli Lilly says late-stage trial of pancreatic cancer treatment failed to meet its main goal of overall survival
Eli Lilly and Co. sa.....»»
Gossamer Bio granted orphan status for pancreatic cancer treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Spherix to acquire USPTO-aproved pancreatic cancer treatment from CBM BioPharma
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck seeing small, midsize deals to expand cancer treatment portfolio, WSJ says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA Greenlights Merck"s Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer
Keytruda, Merck & Co., Inc. read more.....»»
Merck to buy cancer-treatment biotech Tilos Therapeutics for up to $773 million
Merck & Co. Inc. said Monday it was buying privately held biopharmaceutical company Tilos Therapeutics, in a deal that could be valued at up to $773 million. The deal includes an upfront payment and contingent milest.....»»
Merck buys Peloton to expand its kidney cancer treatment portfolio
U.S. drugmaker Merck & Co Inc on Tuesday agreed to buy Peloton Therapeutics Inc for $1.05 billion in cash, gaining access to the privately held company's lead kidney cancer drug candidate......»»
The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa"s Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 14) read more.....»»
Marriott CEO diagnosed with stage 2 pancreatic cancer, will remain in role during treatment
Marriott International Inc. said.....»»
Merck"s Keytruda no better than chemo as a first-line treatment for gastric cancer, according to Phase 3 study results
Merck & Co. Inc. said Friday that a Phase 3 trial evaluating Keytruda as a first-line treatment for gastric cancer failed to show improvement in patients' overall or progression-free survival when compared with chemotherapy. Shares of th.....»»